KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Change in Acquisitions & Divestments: 2023-2024

Historic Change in Acquisitions & Divestments for Castle Biosciences (CSTL) over the last 2 years, with Dec 2024 value amounting to $183.9 million.

  • Castle Biosciences' Change in Acquisitions & Divestments rose 49.18% to $54.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $195.8 million, marking a year-over-year increase of 14.03%. This contributed to the annual value of $183.9 million for FY2024, which is 1.39% down from last year.
  • As of FY2024, Castle Biosciences' Change in Acquisitions & Divestments stood at $183.9 million, which was down 1.39% from $186.5 million recorded in FY2023.
  • In the past 5 years, Castle Biosciences' Change in Acquisitions & Divestments ranged from a high of $186.5 million in FY2023 and a low of $183.9 million during FY2024.
  • Over the past 2 years, Castle Biosciences' median Change in Acquisitions & Divestments value was $185.2 million (recorded in 2023), while the average stood at $185.2 million.
  • Data for Castle Biosciences' Change in Acquisitions & Divestments shows a maximum YoY fell of 1.39% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Castle Biosciences' Change in Acquisitions & Divestments stood at $186.5 million in 2023, then fell by 1.39% to $183.9 million in 2024.